FDA approves Mycapssa for long-term maintenance treatment in acromegaly patients.- Chiasma Inc.,
Chiasma, Inc. announced that the FDA approved Mycapssa (octreotide) capsules for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide…. read more.